(Deanship of Research - Al-Quds University, 2025-06-01) Liza Saadeddin; Yazan AlHabilm; Hana Ishkirat; Mariam Alqam; Obada Hossoon; Seema Hameedi; Hamzeh Yacoub; Diana Yasin; Anita Bahbah; Majd Oweidat; Hanadi Mosa; Yazan AlHabil
Background: Multiple sclerosis (MS) is a complex, heterogeneous disease, and its management remains challenging due to varying symptoms and patient responses to treatments. While injectable therapies like glatiramer acetate and beta-interferon are common, they have limitations such as side effects and varying efficacy. Cannabis has garnered attention as a potential alternative treatment, particularly for symptoms like spasticity and pain.